Data / Federal awards / NAICS 541715 / IIT RESEARCH INSTITUTE
IIT RESEARCH INSTITUTE: 36 federal contract awards, $9.5 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
IIT RESEARCH INSTITUTE (UEI DGBUFQYMKWB5), Chicago, IL, received 36 federal prime contract awards with $9.5 million obligated in fiscal years 2024 to 2027, from 1 agency under 5 NAICS codes. Its largest buyer is Department of Health and Human Services ($9.5 million) and its largest code is NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The request: Every federal contract awarded under NAICS 541715, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- DGBUFQYMKWB5
- Location
- Chicago, IL
- Business size
- Other Than Small Business
- Contract awards
- 36
- Obligated
- $9.5 million
- First action in window
- 2023-10-12
- Latest action
- 2026-09-28
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 17 | $9.3 million |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 8 | $1.2 million |
| 541690 | Other Scientific and Technical Consulting Services | 1 | $-91,999 |
| 541711 | Research and Development in Biotechnology | 3 | $-93,336 |
| 541712 | Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) | 7 | $-736,920 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 36 | $9.5 million |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $5.3 million |
| FY2025 | $1.1 million |
| FY2026 | $3.2 million |
Contract awards
All 36 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N98026F00001 | Department of Health and Human Services | Delivery Order | 541715 | TASK ORDER AWARD- SSL GLP AND NON-GLP TOXICOLOGY STUDIES | $3,391,980 | $3,391,980 | June 25, 2026 | December 25, 2027 | Chicago, IL | usaspending.gov |
| 75N91024F00002 | Department of Health and Human Services | Delivery Order | 541715 | TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531 | $1,790,042 | $1,790,042 | June 12, 2024 | June 11, 2025 | Chicago, IL | usaspending.gov |
| 75N91022C00010 | Department of Health and Human Services | Definitive Contract | 541715 | PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | $1,246,165 | $4,538,201 | April 1, 2022 | March 31, 2027 | Chicago, IL | usaspending.gov |
| 75N91020F00001 | Department of Health and Human Services | Delivery Order | 541714 | PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR | $1,014,245 | $1,736,011 | September 8, 2020 | May 7, 2025 | Chicago, IL | usaspending.gov |
| 75N91024F00003 | Department of Health and Human Services | Delivery Order | 541715 | TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102 | $627,793 | $627,793 | September 16, 2024 | October 31, 2026 | Chicago, IL | usaspending.gov |
| 75N95024F00002 | Department of Health and Human Services | Delivery Order | 541715 | FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS | $547,006 | $547,006 | September 18, 2024 | December 31, 2025 | Chicago, IL | usaspending.gov |
| 75N95024F00002 | Department of Health and Human Services | Delivery Order | 541715 | IITRI - PTTP DRF BPN STUDY - TO3 | $438,148 | $438,148 | March 1, 2024 | February 28, 2025 | Chicago, IL | usaspending.gov |
| 75N95025F00001 | Department of Health and Human Services | Delivery Order | 541715 | PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIES | $401,373 | $401,373 | September 26, 2025 | September 25, 2026 | Chicago, IL | usaspending.gov |
| 75N95024F00003 | Department of Health and Human Services | Delivery Order | 541715 | IITRI -DOG MTD-DRF STUDIES-TO 4 | $224,716 | $224,716 | March 15, 2024 | December 15, 2024 | Chicago, IL | usaspending.gov |
| 75N95024F00001 | Department of Health and Human Services | Delivery Order | 541715 | IITRI - PERFORMANCE AREA 1 TO2 | $212,495 | $212,495 | March 1, 2024 | February 28, 2027 | Chicago, IL | usaspending.gov |
| 75N95024F00004 | Department of Health and Human Services | Delivery Order | 541715 | IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2 | $201,969 | $201,969 | July 22, 2024 | June 2, 2025 | Chicago, IL | usaspending.gov |
| 75N95020F00001 | Department of Health and Human Services | Delivery Order | 541712 | NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020. | $166,060 | $3,053,804 | September 16, 2020 | September 30, 2024 | Chicago, IL | usaspending.gov |
| 75N91020F00001 | Department of Health and Human Services | Delivery Order | 541714 | TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022 | $147,609 | $1,161,990 | September 21, 2020 | January 31, 2026 | Chicago, IL | usaspending.gov |
| 75N95020F00002 | Department of Health and Human Services | Delivery Order | 541712 | TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2 | $143,468 | $2,373,515 | September 17, 2020 | October 31, 2025 | Chicago, IL | usaspending.gov |
| 75N98026F00002 | Department of Health and Human Services | Delivery Order | 541715 | IITRI - PA1 TASK ORDER #07 | $108,506 | $108,506 | September 12, 2026 | September 11, 2027 | Chicago, IL | usaspending.gov |
| 75N91026F00001 | Department of Health and Human Services | Delivery Order | 541715 | TOXICOLOGY STUDIES IN MICE ADMINISTERED MTX-531 - FINAL DELIVERABLES | $68,323 | $68,323 | February 9, 2026 | May 9, 2026 | Chicago, IL | usaspending.gov |
| 75N98026F00003 | Department of Health and Human Services | Delivery Order | 541715 | IITRI - 2026 SF IND-ENABLING GLP TOXICOLOGY STUDIES | $46,385 | $46,385 | September 15, 2026 | March 14, 2028 | Chicago, IL | usaspending.gov |
| 75N91018F00005 | Department of Health and Human Services | Delivery Order | 541711 | IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL | $36,096 | $1,984,676 | September 17, 2018 | July 25, 2025 | Chicago, IL | usaspending.gov |
| 75N91019D00012 | Department of Health and Human Services | IDC | 541714 | PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS (POP: 1/25/2019-1/24/2024). | $0 | $74,995,000 | January 23, 2019 | usaspending.gov | ||
| HHSN261201500024I | Department of Health and Human Services | IDC | 541711 | IGF::OT::IGF ICIQ CONTRACT TITLED PRECLINICAL PREVENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY | $0 | $19,000,000 | September 22, 2015 | usaspending.gov | ||
| 75N91019D00013 | Department of Health and Human Services | IDC | 541714 | BASE IDIQ CONTRACT FOR "PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY TESTING"; POP: 1/25/2019-1/24/2024. | $0 | $74,995,000 | January 23, 2019 | usaspending.gov | ||
| 75N91022D00016 | Department of Health and Human Services | IDC | 541715 | PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | $0 | $9,838,435 | September 26, 2022 | usaspending.gov | ||
| 75N93024D00012 | Department of Health and Human Services | IDC | 541714 | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREAS A AND B | $0 | $146,300,000 | July 15, 2024 | usaspending.gov | ||
| 75N95022F00001 | Department of Health and Human Services | Delivery Order | 541712 | NON-CLINICAL SAFETY ASSESSMENT OF COVALENT BI-TOX TO SUPPORT NEUROPATHIC PAIN INDICATION | $0 | $765,995 | September 23, 2022 | April 29, 2025 | Chicago, IL | usaspending.gov |
| 75N91022F00001 | Department of Health and Human Services | Delivery Order | 541715 | CONTRACT ORIENTATION & KICKOFF MEETING FOR R&D SERVICES UNDER "PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER | $0 | $3,000 | September 26, 2022 | April 25, 2025 | Chicago, IL | usaspending.gov |
| 75N91024D00001 | Department of Health and Human Services | IDC | 541714 | PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY TESTING | $0 | $149,995,000 | January 25, 2024 | usaspending.gov | ||
| 75N95021D00026 | Department of Health and Human Services | IDC | 541715 | ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR THERAPEUTICS PROGRAM (PTTP) | $0 | $174,470,000 | September 29, 2021 | usaspending.gov | ||
| 75N95024D00020 | Department of Health and Human Services | IDC | 541715 | SAFETY EVALUATION AND TOXICOLOGY STUDIES AND RELATED SERVICES FOR DRUG DEVELOPMENT | $0 | $48,622,546 | June 20, 2024 | usaspending.gov | ||
| HHSF223201510000I | Department of Health and Human Services | IDC | 541712 | IGF::OT::IGF, IN VITRO TOXICOLOGY OF TOBACCO AND RELATED PRODUCTS | $0 | $0 | June 30, 2015 | usaspending.gov | ||
| 75N91021F00001 | Department of Health and Human Services | Delivery Order | 541714 | EVALUATION OF AFPEP FOR THE PREVENTION OF BREAST CANCER | $-2,781 | $532,562 | September 6, 2021 | July 31, 2024 | Chicago, IL | usaspending.gov |
| 75N95019F00090 | Department of Health and Human Services | Delivery Order | 541712 | GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/ | $-2,908 | $547,622 | September 1, 2019 | October 30, 2020 | Chicago, IL | usaspending.gov |
| 75N91023F00001 | Department of Health and Human Services | Delivery Order | 541714 | BASE TITLE: PREVENT PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TASK ORDER TITLE: NICOTINE REDUCTION THERAPY USING THE HUMAN MONOCLONAL ANTIBODY | $-2,912 | $656,577 | September 22, 2023 | April 25, 2025 | Chicago, IL | usaspending.gov |
| 75N95019F00091 | Department of Health and Human Services | Delivery Order | 541712 | NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/ | $-35,321 | $1,156,165 | September 1, 2019 | August 31, 2021 | Chicago, IL | usaspending.gov |
| HHSN26100003 | Department of Health and Human Services | Delivery Order | 541690 | IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS | $-91,999 | $626,266 | September 6, 2017 | September 30, 2022 | Chicago, IL | usaspending.gov |
| 75A50118F33002 | Department of Health and Human Services | Delivery Order | 541711 | IGF::OT::IGF | $-129,432 | $2,437,669 | September 24, 2018 | September 30, 2021 | Chicago, IL | usaspending.gov |
| 75N95020F00003 | Department of Health and Human Services | Delivery Order | 541712 | NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 | $-1,008,219 | $751,371 | September 25, 2020 | December 31, 2024 | Chicago, IL | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- All recipients under NAICS 541690 Other Scientific and Technical Consulting Services
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 541714
- Open opportunities under NAICS 541690
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.